Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
35.07
-1.86 (-5.04%)
At close: Aug 20, 2025, 3:59 PM
35.42
1.00%
After-hours: Aug 20, 2025, 07:43 PM EDT

Caris Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q2 2024 Q1 2024 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Jun 30, 2024 Mar 31, 2024 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-351.58M -279.8M -177.21M -111.03M 139.08M 103.37M 64.8M
Depreciation & Amortization
42.77M 36.36M 29.32M 17.7M 114.85M 112.59M 111.7M
Stock-Based Compensation
51.93M 23.63M 8.94M 4.46M 2.06M 2.11M 1.44M
Other Working Capital
-19.14M 6.56M 1.48M -52K 73.82M 27.39M -96.12M
Other Non-Cash Items
89.41M 43.59M 7.41M 16.12M -16.23M 62.54M 199.84M
Deferred Income Tax
n/a n/a n/a n/a 7.59M 1.29M 3.93M
Change in Working Capital
6.58M 8.02M -5.3M -1.18M 91.13M 31.55M -89.04M
Operating Cash Flow
-160.9M -168.19M -136.85M -73.92M 338.49M 313.45M 292.68M
Capital Expenditures
-8.4M -7.01M -4.33M -1.74M -992.13M -463.25M -363.29M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
61.38M 61.38M 61.38M 61.38M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a 198.63M 199.18M 182.51M
Investing Cash Flow
52.98M 54.36M 57.05M 59.64M -793.5M -264.07M -180.78M
Debt Repayment
223.69M 199.85M 199.87M 199.9M n/a n/a n/a
Common Stock Repurchased
-22K -22K n/a n/a -20.73M -20.73M -20.73M
Dividend Paid
n/a n/a n/a n/a -28.88M -28.1M -22.9M
Other Financial Acitivies
130.54M 1.44M 111K 210K 163.75M -45.88M -168.72M
Financial Cash Flow
882.67M 201.26M 199.98M 200.11M 134.88M -73.98M -191.62M
Net Cash Flow
774.85M 87.45M 120.19M 185.82M -320.13M -18.82M -73.94M
Free Cash Flow
-169.3M -175.2M -141.18M -75.66M -653.64M -149.79M -70.61M